News
Read the latest press releases and news articles about transplantation medicine, innovations in the care of transplant patients and ImmunoFree.
Gene-edited pig kidney transplanted into a third person, moving xenotransplants closer to trials
In yet another sign of xenotransplantation creeping toward reality, a medical team at NYU Langone Health announced Tuesday that, for the third time, a kidney from a genetically modified pig had been transplanted into a living patient.
OHSU accused of negligence in use of experimental treatment
A new lawsuit filed Aug. 20 in federal court in Portland sheds light on the enormous financial and human costs of the complex clinical trials that underlie modern pharmaceutical breakthroughs.
Dr. Joe Leventhal Honored with Prestigious Terasaki Innovation Award
At its 2024 Awards Gala, held June 20, 2024, at The Plaza Hotel in New York City to honor kidney donors and the achievements of the American transplant industry, the National Kidney Registry presented the Terasaki Medical Innovation Award to Dr. Joe Leventhal. The Terasaki Medical Innovation Award is given to an individual or organization…
Dr. Robert Montgomery Honored with the Prestigious ACS Jacobson Award
Immunofree, a company advancing stem cell technology to eliminate the need for immunosuppressive medications in transplant patients, congratulates Dr. Robert Montgomery on winning the prestigious Jacobson Innovation Award from the American College of Surgeons. The award was presented to Dr. Montgomery on June 14, 2024, at the Chicago History Museum at a dinner in his…
First-ever combined heart pump & gene-edited pig kidney transplant gives new hope to patient with terminal illness
Surgeons at NYU Langone Health performed the first combined mechanical heart pump and gene-edited pig kidney transplant surgery.
The bone-marrow-transplant revolution
In the fall of 2021, Gabriel Arias felt like his body was “rotting from the inside.” He was diagnosed with acute myeloid leukemia, a form of blood cancer so aggressive that doctors had him hospitalized the day of his biopsy.
Drs. Fuchs and Leventhal Present Important Clinical Immune Tolerance Research at the 6th International Sam Strober Workshop
Drs. Ephraim Fuchs and Joseph Leventhal were among the esteemed speakers at the 6th International Sam Strober Workshop on Clinical Immune Tolerance Research, which was held March 25–26, 2024, at Oxford University’s Exeter College. This year’s event, with a focus on autoimmunity, aimed to expand the dialogue surrounding transplantation tolerance and autoimmune regulation. Drs. Fuchs…
National Kidney Foundation Innovation Fund Invests in ImmunoFree
The National Kidney Foundation (NKF) announced today its latest strategic investment through its NKF Innovation Fund. The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.
Dr. Ephraim Fuchs Joins ImmunoFree, Inc. as its Chief Medical Officer
Today, ImmunoFree, Inc. announced that Dr. Ephraim Fuchs has been appointed the Chief Medical Officer of ImmunoFree. In his role as CMO, Dr. Fuchs will oversee all medical and scientific affairs of the company and be responsible for the development of the ImmunoFree tolerance protocol for the 1,000,000+ transplant recipients worldwide who can benefit from…